Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-25-000813
Filing Date
2025-11-20
Accepted
2025-11-20 17:37:42
Documents
1
Period of Report
2025-11-18

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3709
  Complete submission text file 0001012975-25-000813.txt   5109
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Issuer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address
Mukadam Sophie (Reporting) CIK: 0002050122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39267 | Film No.: 251504069